Country Regulatory Affairs -

March 30, 2026
Mexico's Regulation: COFEPRIS Eliminates the Review of Notices as Part of Administrative Simplification - Drugs
March 30, 2026
Mexico's Regulation: The National Center for Pharmacovigilance and Technovigilance (CENAFyT) is Created -Drugs
March 30, 2026
Colombia's Regulation: Information for Requesting Good Practice Certification Visits Manufacturing (BPx) - Drugs
March 30, 2026
Colombia's Regulation: Decree of 2026: Regulating the Operation of Establishments Dedicated to the Extraction, Processing, Preservation, and Distribution of Blood and Blood Components and Medicinal Products Derived From Plasma and Serum, and Other Provisi
March 30, 2026
Brazil's Regulation: The Highlights of the 3rd Dicol Public Meeting of 2026: Updated Rules Approved in the Sanitary Control of Foreign Trade and the List of Reference Medicines
March 30, 2026
Brazil's Regulation: Resolution of the ANVISA Collegiate Board No. 1018, of March 6, 2026: Amends Collegiate Board Resolution No. 977, of June 5, 2025, Which Provides for ANVISA's Administrative Control in Foreign Trade Operations of Goods and Products Su
March 30, 2026
ANVISA Expands Project to Reduce Review Queues for Biological Products
March 30, 2026
ANVISA Introduces Solicita Profile for Fee Payment Management
March 30, 2026
ANVISA Resolution 1018/2026 Updates Foreign Trade Regulatory Control Framework
March 30, 2026
New Subject Code Introduced for Bioequivalence Study Petitions
March 30, 2026
ANVISA Updates COVID Vaccine and Low-Risk Medicines Classification
October 31, 2025
COFEPRIS Publishes Technical Guide for the Recognition of Orphan Medicines (CTD-based)